April 23, 2026 10:00 AM EDTUpdated 10:36 AM Manufacturing Amneal to buy a biosimilar company; Samsung Bio workers protest Anna Brown News Reporter Plus, news about Avonik, a supply chain transparency bill and Nucleus RadioPharma: 💰 Amneal Pharmaceuticals to acquire biosimilar maker for $375M upfront: The generics and … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
83 words · extracted 2mo agoread original ↗
comments(0)
5-min edit window · permanent after that